Articles in News
The findings from the Buxbaum lab point to new approach to Alzheimer’s prevention and therapy.
A team from the Lazzerini Denchi lab shows a path to DNA damage that provides fertile ground for cancer.
LA JOLLA—The Salk Institute for Biological Studies has received a $25 million gift from San Diego philanthropist and former Salk trustee Conrad T. Prebys to support cutting-edge biological research on a wide range of diseases.
Reversible memory produced in rats gives clues to treating memory loss from dementias.
Donation is largest to date for Salk’s $300 million endowment campaign.
A forthcoming downtown convention will provide a platform for area companies to tout San Diego as one of the country’s most innovative hubs for biotechnology.
Venture capital investment in San Diego’s life sciences arena is on the upswing, boosted by the lingering positive effects of a bullish biotech market, according to area VCs and a new report from PriceWaterhouseCoopers LLP.
The role of data and technological innovation in health care was front and center at a conference of top health experts from academia, industry and government, convened by the New York Times at the…
[[Click headline to continue reading.]]
California’s stem cell agency has awarded $14.3 million to resume clinical trials.
LA JOLLA—Pedal the Cause, the region’s only multiday cycling fundraiser where 100 percent of the net proceeds goes to support cancer research in San Diego, today announced five research projects funded by the inaugural 2013 event. The Pedal the Cause grants offer enough support for initial experiments, which will ideally lead to grants from federal sources and to large-scale studies.